Due to an increase in the need for advanced diagnostic solutions and the growing chronic diseases, as well as a shift in automated blood collection methods, the global market for vacuum blood collection devices is expected to grow rapidly.
Because early diagnosis and precision medicine are gaining more focus in healthcare, these devices are essential for accurate and efficient blood sampling. Major players in the market include Becton Dickinson, Greiner Bio-One, and Cardinal Health, which hold nearly half of the share. Their success is based on continually improving blood collection technologies and ensuring patient safety.
| Attribute | Details |
|---|---|
| Projected Value by 2035 | USD 5,407.56 million |
| CAGR during the period 2025 to 2035 | 6.4% |
Regional manufacturers and emerging biotech companies are carving out about 30% of the market by offering specialized and cost-effective solutions that cater to specific healthcare needs. Such firms are making the collection of blood more accessible and affordable in the local markets.
The remaining 20% market share is commanded by innovative start-ups and medical institutions. The organizations are investing in the state-of-the-art blood sampling techniques to enhance diagnostic accuracy, efficiency, and precision. Their work is taking the blood collection to the next level, and the future generations of devices will be even more reliable and effective.
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
| Global Market Share | Industry Share % |
|---|---|
| Top 3 (Becton Dickinson & Company ,Greiner Bio-One GmbH, Cardinal Health ) | 49.9% |
| Top 5 (Becton, Dickinson, & Company, Greiner Bio-One GmbH, Cardinal Health, SARSTEDT AG & Co. KG, Sekisui Medical ) | 17.0% |
| Chinese Suppliers (Zhejiang Gongdong Medical Technology Co., Ltd. SHANDONG AOSAITE MEDICAL DEVICES CO., LTD and others) | 12.0% |
| Niche and Regional Players | 21.1% |
| Market Concentration, 2025 | Assessment |
|---|---|
| High (more than 60% by top players) | Medium |
| Medium (40 to 60% by top 10 players | High |
| Low (less than 30% by top players) | Low |
With an increasingly required accuracy level of diagnostic tests, serum separation tubes have garnered the major part of the market share. It supports precise detection of biomarkers through serum tubes and assists in diagnosis. Clot activators present in the form of serum gel with clot activators, silica, or even thrombin-coated tubes enhance the serum clotting as well as ensure adequate yield so that reliable tests could be acquired.
Plasma analysis tubes, including EDTA, lithium heparin, and sodium heparin tubes, play a crucial role in haematology and plasma-based testing. Specialized tubes include coagulation analysis tubes and glucose analysis tubes with sodium fluoride, potassium fluoride, and fluoride oxide for specific diagnostic purposes, ensuring the integrity of the sample for extended periods.
PET/plastic-based vacuum blood collection tubes dominate the market due to their durability, lightweight nature, and resistance to breakage, ensuring enhanced patient safety and ease of disposal. Glass tubes, while traditionally preferred for their excellent chemical stability, are gradually being replaced by PET tubes as healthcare facilities seek safer and more convenient options for blood collection.
2024 has witnessed key advancements in vacuum blood collection technologies, with major players introducing innovative solutions for improved diagnostics:
Becton Dickinson (Advanced Blood Collection Systems): Becton Dickinson-Advanced Blood Collection Systems: The BD has safety-engineered the blood collection tubes with advanced protection technology for the needle and designs of closed system to minimize all risks of contamination and needle stick injuries.
Innovation is improving comfort for patients while increasing diagnostic accuracies and facilitation of drawing blood in any hospital, laboratory, or any diagnostic centre because of higher standards of safety at all levels-in health care provision and for patient and healthcare professional alike.
Greiner Bio-One (Innovative Clot Activator Technology): Greiner has developed the next generation of clot activator tubes that activate coagulation much faster than previous ones. This will allow a shorter sample processing time with greater test reliability. The efficiency of serum separation improves, while clotting variability decreases. Such new-generation clot activator tubes set a new industry standard by using advanced surface coatings and optimised activator formulations to enable blood analysis that is both highly precise and highly efficient.
Sarstedt (Improved Plasma Collection Tubes): Sarstedt has improved plasma collection tubes with new formulated anticoagulants, improving sample stability and reducing coagulation variances; they are also efficient in plasma separation. These innovations have enabled the achievement of accurate and reproducible diagnostics, especially in coagulation studies and molecular diagnostics, hence its importance in modern laboratory use and research.
Sekisui Medical Ltd: The vacuum blood collection devices market creates a large pool of opportunities to grow in size for Sekisui Medical Ltd, mainly backed by several critical factors in health care. From innovation to adhering to new regulations and further strategic market presence, Sekisui Medical has the scope of increasing its global market share.
Cardinal Health: Cardinal Health operates in a dynamic and competitive market. They have scopes to grow through innovation, strategic alliances, and the pursuit of sustainability. Staying aligned to competitive trends and regulation requirements will ensure that the company remains in a leading position as a vacuum blood collection devices vendor.
Market Growth Rate: Market for vacuum blood collection devices will grow at a strong CAGR during the forecast period, between 2023 and 2028. Rising healthcare expenditure along with the adoption of advanced technologies in diagnostics can be considered some of the significant growth factors in this market.
Rising Chronic Diseases: Increasing the prevalence of chronic diseases like diabetes, cancer, and cardiovascular conditions worldwide, the need for blood collection devices will consequently rise, due to the complexity and strict accuracy of any related testing that may be required.
Technological Innovation: Innovations such as safety-engineered devices and automated blood collection systems are gaining momentum. These technologies would enhance the safety and efficiency of blood collection with reduced risk for needle stick injuries.
Geographical Insight: North America is likely to lead the market as the biggest medical device manufacturing companies are headquartered here, along with an established healthcare infrastructure. However, Asia Pacific is going to have the highest growth rate, primarily because of increasing health care access and investments by the government in healthcare facilities.
Regulatory landscape: Compliance with strict standards of health authorities including FDA and CE marking in Europe plays an essential role. Companies focusing on regulatory approval and quality standards will have better chances to thrive in this market.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
| Tier | Market Share (%) |
|---|---|
| Tier 1 (Becson, Dickinson and co., Greiner Bio-one and Cardinal Health, SARSTEDT AG & Co. , Sekisui Medical Ltd) | 66.9% |
| Tier 2 (HEBEI XINLE SCI&TECH CO., LTD, Guangzhou Improve Medical Instruments Co. Ltd,) | 21.6% |
| Tier 3 (FL Medical, Biosigma S.r.l, CHENGDU RICH SCIENCE INDUSTRY CO., LTD., AB Medical Inc., Poly Medicure Ltd) | 11.5% |
| Company Name | Unique Initiative |
|---|---|
| Becton, Dickinson and Company (BD) | BD is one of top researcher in the technological development of blood collection. The company came up with BD Right Gauge Technology, which works on designing of thinner needles to make the process of blood collection more comfortable for patients. |
| Greiner Bio-One GmbH | The company designs a range of blood collection tubes and devices for specific diagnostic requirements.. |
| Cardinal Health | The cardinal health is a firm that has engaged in strategic acquisition and product development in an attempt to advance its offerings in the blood collection market. |
| SARSTEDT AG & Co. KG | SARSTEDT AG & Co. KG SARSTEDT has introduced innovations in blood collection from capillary. This firm delivers several micro-blood collection systems targeting different groups of patients such as neonates and geriatrics. |
| Sekisui Medical | Sekisui Medical has been investing in the development of advanced blood collection devices. The company focuses on creating products that enhance sample integrity and patient safety. |
Investment in Smart Blood Collection Technologies: Organizations should implement Internet of Things - and AI-led tracking systems so that sample tracing is enhanced; human errors decreased; and patient diagnosis accuracy can be improved with smart labelling coupled with real-time data monitoring streamlining laboratory operations and optimizing results for patients.
Expansion into Emerging Markets: Distribution network strength in the developing healthcare region will push further market penetration and revenue growth. Local partnerships along with compliance to regional regulations would accelerate adoption even further and allow better access to high-quality blood collection solutions.
Advancement of Sustainable Manufacturing Practices: Using eco-friendly materials, biodegradable plastics, and energy-efficient production processes will be in line with global environmental policies. The sustainable initiatives will enhance brand reputation and meet the increasing demand for green healthcare solutions.
Increased direct-to-consumer awareness: Such programs will drive education among doctors and patients themselves regarding new approaches in blood sampling. Digital, social media as well as advertising in medical gatherings will increase overall adoption.
Product lines tailored for veterinary specific blood collection tools: Expanding into veterinary diagnostic equipment will serve the growing diagnostics industry. Further, innovations adapted for pet, as well as livestock health management, will deliver enhanced diagnostic ability, thus building the veterinary segment.
Integration of AI in Blood Collection
Artificial intelligence is making a big impact on blood collection, such as helping track samples in real time and error reduction. The technology makes processes more accurate and efficient in ensuring that the results we rely on are more trustworthy.
Advancement in Micro-Sampling Techniques
There is much advancement into smaller, less invasive methods of collecting blood. Micro-sampling techniques aim to make the process as painless for patients as possible while capturing all the required information at a diagnostic level.
Widening Molecular Diagnostic Applications & Geographical Extensiveness of Automated Collection Systems
Molecular diagnostics are becoming increasingly popular using vacuum blood collection devices, particularly in genetic testing and biomarker analysis. It opens up doors to new levels of personalized medicine. On the other hand, automated collection systems are being introduced all over the world to increase the uniformity and efficiency in processing blood samples in health facilities, thus becoming more reliable for all.
The global Vacuum Blood Collection Market is projected to witness CAGR of 6.4% between 2025 and 2035.
The global Vacuum Blood Collection industry stood at USD 2,721.40 million in 2024.
The global Vacuum Blood Collection Market is anticipated to reach USD 5,407.56 million by 2035 end.
India is set to record the highest CAGR of 7.2% in the assessment period.
The key players operating in the global Vacuum Blood Collection space include Becson, Dickinson and co., Greiner Bio-one and Cardinal Health, SARSTEDT AG & Co., Sekisui Medical Ltd, etc.
Explore Medical Supplies Insights
View Reports
Vacuum Blood Collection Devices Market Share Analysis
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
